Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
暂无分享，去创建一个
K. Hood | P. Barrett-Lee | A. Casbard | G. Griffiths | R. Coleman | P. Simmonds | J. Abraham | D. Wheatley | R. Grieve | N. Murray | H. Timmins | Hayley Timmins